ORIENT BIO Inc. Stock Price

ORIENT BIO Inc. operates in the bio-industry in South Korea and internationally. It engages in the production, export, import, and life science-related research and development of laboratory animals; and offers various equipment for research environment. The company also provides infrastructural solution; health checking; generic testing; molecular biological generic testing; generic transformation; phenotyping; preconditioning; surgical treatment; transgenic services; eggs and avian research; support services for husbandry tasks; diagnostic and kits; claim management; serology regents; supply of biological materials used for new drug development process; and mouse, rat, and hamster antibody production testing services. In addition, it engages in automotive and automobile parts production and sales; preclinical and clinical trial agency business; manufacturing, import, and export pharmaceuticals, manufacturing, processing, wholesaling, and retailing of watches; and construction works. It has strategic partnerships with ELLEGARD in the Netherlands and CSIMC in China. It serves research institutions, pharmaceutical companies, and healthcare providers. The company was formerly known as Orient Co., Ltd. and changed its name to ORIENT BIO Inc. in 2005. ORIENT BIO Inc. was founded in 1959 and is headquartered in Seongnam-si, South Korea.